Genenta Science S.p.A.
GNTA
$4.25
$0.07721.85%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 2.90% | 4.96% | -14.87% | -12.85% | -21.42% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.30% | 7.42% | -34.30% | -32.74% | -24.56% |
| Operating Income | -5.30% | -7.42% | 34.30% | 32.74% | 24.56% |
| Income Before Tax | 1.23% | -0.76% | 40.92% | 39.52% | 19.12% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 1.23% | -0.76% | 40.92% | 39.52% | 19.12% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.23% | -0.76% | 40.92% | 39.52% | 19.12% |
| EBIT | -5.30% | -7.42% | 34.30% | 32.74% | 24.56% |
| EBITDA | -5.31% | -7.42% | 34.42% | 32.86% | 24.85% |
| EPS Basic | 1.66% | -0.34% | 41.06% | 39.65% | 19.10% |
| Normalized Basic EPS | 1.55% | -0.33% | 41.05% | 39.66% | 19.18% |
| EPS Diluted | 1.66% | -0.34% | 41.06% | 39.65% | 19.10% |
| Normalized Diluted EPS | 1.55% | -0.33% | 41.05% | 39.66% | 19.18% |
| Average Basic Shares Outstanding | 0.40% | 0.40% | 0.22% | 0.22% | 0.00% |
| Average Diluted Shares Outstanding | 0.40% | 0.40% | 0.22% | 0.22% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |